tert-Butyl (2-oxopropyl)carbamate

Catalog No. :
ACFCHX728
CAS No. :
170384-29-9
Molecular Formula :
C8H15NO3
Molecular Weight :
173.21

IUPAC Name:tert-butyl (2-oxopropyl)carbamate

tert-Butyl (2-oxopropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$52.00Login to see priceIn stockInquiry
100g97%$154.00Login to see priceIn stockInquiry
500g97%$615.00Login to see priceIn stockInquiry
1000g97%$984.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-oxopropyl)carbamate
IUPAC Nametert-butyl (2-oxopropyl)carbamate
MDL No.MFCD10698678
Molecular FormulaC8H15NO3
Molecular Weight173.21
SMILESC(C)(C)(C)OC(NCC(C)=O)=O
InChI KeyOZGMUQGCAFEQOX-UHFFFAOYSA-N
Synonym170384-29-9 | tert-Butyl (2-oxopropyl)carbamate | (2-Oxopropyl)carbamic acid tert-butyl ester | tert-butyl N-(2-oxopropyl)carbamate | tert-Butyl 2-oxopropylcarbamate | tert-butyl N-acetonylcarbamate | MFCD10698678 | 1-(Boc-amino)-2-oxopropane | NSC617629 | (2-Oxo-propyl)-c
CAS No.170384-29-9
PubChem CID357955

Safety Data

Pictogram
Harmful or irritant
Signal Word
Gefahrenhinweise
Hazard Statement(s)
H302-H412
Precautionary Statement(s)
P273

Synthetic Route by SureRoute

1. ACFCHX728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBKLF641 route compound structure diagram
    ACBKLF64195656-86-3 In Stock
  2. Then
  3. ACFCHX728 route product structure diagram
    ACFCHX728170384-29-9 In Stock
Inquiry

2. ACFCHX728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSTXD462 route compound structure diagram
    ACSTXD462121505-93-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFCHX728 route product structure diagram
    ACFCHX728170384-29-9 In Stock
Inquiry

Comments (0)